Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

Catalent lays off workers, expands clinical supply facility in Shanghai

By Brian Buntz | December 1, 2022

CatalentContract manufacturing giant Catalent has wrapped up the expansion of a clinical supply facility in the Waigaoqiao Free Trade Zone (FTZ) in Shanghai, China.

The company is also cutting 400 temporary and full-time workers in Bloomington, Indiana and more than 210 workers in Texas and Maryland.

In a statement from Bloomington, Indiana Mayor John Hamilton blames the layoffs on cooling demand for COVID-19 therapies. “My understanding is that in responding to the pandemic, Catalent significantly ramped up operations to accommodate the manufacturing of life-saving vaccines, but at present, the same volume of production is not necessary and thus is not economically sustainable as before,” Hamilton said.

After an inspection this summer, the FDA recommended that Catalent conduct voluntary quality improvements at the Bloomington site.

In addition, Catalent has halted construction on the Vaccine Manufacturing and Innovation Centre near Oxford in the United Kingdom, according to The Times. The company announced that it acquired the site in April. Slowing COVID-19 revenues are also reportedly to blame for the decision. In April, the company said it would invest £120 million in the facility’s construction.

The expansion of the clinical supply facility in Shanghai resulted in an increase of roughly 30,000 ft2, accommodating additional refrigerated and deep-frozen storage. The site also has room for additional secondary packaging equipment.

Catalent will commemorate the completion of the Shanghai site with two customer events scheduled for December 1 and 6. At the event, senior management will demonstrate the capabilities of the revamped clinical supply site and hold workshops on clinical supply management and new GMP policies.

Catalent has two clinical supply facility sites in Shanghai, with another in Tangzhen, outside the Free Trade Zone (FTZ).

The company offers a range of clinical supply management services in China, including comparator sourcing, demand-led supply, packaging, storage and global distribution. It also provides clinical returns and destruction.

Catalent has announced a series of expansions during the pandemic. In 2021, it expanded a biologics manufacturing site in Wisconsin. That same year, it also acquired Acorda’s manufacturing and packaging operations.

About The Author

Brian Buntz

The pharma and biotech editor of WTWH Media, Brian is a veteran journalist with more than 15 years of experience covering an array of life science topics, including clinical trials, drug discovery and development and medical devices. Before coming to WTWH, he served as content director focused on connected devices at Informa. In addition, Brian covered the medical device sector for 10 years at UBM. At Qmed, he overhauled the brand’s news coverage and helped to grow the site’s traffic volume dramatically. He had previously held managing editor roles on two of the company’s medical device technology publications. Connect with him on LinkedIn or email at bbuntz@wtwhmedia.com.

Tell Us What You Think! Cancel reply

Related Articles Read More >

Great Point Partners logo.
Great Point Partners acquires majority stake in Eutecma to fuel sustainable cold chain growth
Driving success in fast-paced high-tech pharma construction projects
This is a photo of the Fujifilm Diosynth Biotechnologies plant under construction in Holly Springs, North Carolina.
Fujifilm, Regeneron ink $3B U.S. manufacturing agreement
This is the logo of Johnson & Johnson.
J&J breaks ground on $2B manufacturing facility in North Carolina
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE